Evonile Pharma Limited (NSE:EVONILE)

Evonile Pharma Revenue

Evonile Pharma had revenue of 637.90M INR in the quarter ending September 30, 2026, a decrease of -29.38%. This brings the company's total for the last twelve months to 3.33B, down -6.20% year-over-year. In the fiscal year ending March 31, 2026, Evonile Pharma had annual revenue of 3.54B, down -0.54%.

• Revenue (ttm): 3.33B
• Revenue Growth: -6.20%
• P/S Ratio: 13.67
• Revenue / Employee: 59.00M
• Employees: 57
• Market Cap: 45.96B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	3.54B	-19.40M	-0.54%
Mar 31, 2025	3.56B	212.00M	6.33%
Mar 31, 2024	3.35B	-436.70M	-11.53%
Mar 31, 2023	3.79B	-211.30M	-5.28%
Mar 31, 2022	4.00B	185.20M	4.86%

Data Source: S&P Global Market Intelligence Last updated: Nov 3, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 9, 2026

Data Sources Report a data error